CACLP - The largest IVD Expo & Conference

FDA Grants Breakthrough Designation for Novel Bladder Cancer Diagnostic

Industry news | 03 July, 2025 | CACLP

Original from: Targeted Oncology

 

The TOBY Test has received breakthrough device designation from the FDA for the early detection of bladder cancer. This designation underscores the significant potential of this innovative urine-based assay to fundamentally alter the landscape of bladder cancer detection and surveillance, offering a much-needed non-invasive alternative to current diagnostic paradigms.

 

The TOBY Test represents a sophisticated advancement in cancer diagnostics, leveraging the power of urine-based volatilomics combined with AI algorithms. At its core, the technology analyzes volatile organic compounds present in a single urine sample using gas chromatography-mass spectrometry. Proprietary AI then processes these intricate chemical signatures to generate a real-time cancer risk score, providing clinicians with a novel tool for assessment. This one-step, painless procedure contrasts sharply with the invasive and often uncomfortable methodologies that currently dominate bladder cancer management.

 

Bladder cancer, while the sixth most common cancer in the US, poses unique challenges in its clinical management, primarily due to its high recurrence rate and the subsequent necessity for frequent, invasive surveillance. Cystoscopy, the current gold standard for diagnosis and monitoring, involves the insertion of a rigid or flexible tube with a camera into the bladder, a procedure that, while effective, can be distressing for patients and contributes significantly to the overall cost burden of the disease. The reliance on such invasive tools for ongoing surveillance translates into substantial healthcare expenditures and patient discomfort, highlighting a critical unmet need for more accessible and less burdensome diagnostic options.

 

Source: FDA Grants Breakthrough Designation for Novel Bladder Cancer Diagnostic

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 1808, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference